Pfizer Q3 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,870
-114.50 (-2.30%)
-114.50 (-2.30%)Volume812.00
Updated: Fri 14 Aug, 2026 | 15:28:39
NSE
4,864-126.40 (-2.53%)
-126.40 (-2.53%)Volume11.70 K
Updated: Fri 14 Aug, 2026 | 15:29:49
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Pfizer Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 489.30 | 414.33 | 14.67% | 397.02 | 20.28% |
| Depreciation/ Amortization | 14.26 | 14.99 | -0.14% | 17.55 | -3.65% |
| Operating Income | 155.73 | 174.26 | -27.79% | 142.95 | 18.71% |
| Net Income | 141.84 | 158.35 | -24.96% | 129.98 | 11.16% |
| Other Operating Expenses Total | 91.77 | 87.86 | 2.21% | 115.49 | -7.44% |
| Net Income Before Taxes | 191.95 | 215.23 | -24.83% | 175.94 | 11.31% |
| Total Revenue | 645.03 | 588.59 | 0.42% | 539.97 | 19.90% |
| Selling/ General/ Admin Expenses Total | 100.30 | 100.76 | 5.95% | 89.37 | 4.16% |
| Diluted Normalized EPS | 40.41 | 34.61 | -2.20% | 27.14 | 44.90% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.